Rockwell Medical (RMTI) Competitors

Rockwell Medical (NASDAQ:RMTI) and Accuray (NASDAQ:ARAY) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, valuation, analyst recommendations, media sentiment, profitability and earnings.

Which has stronger valuation & earnings, RMTI or ARAY?

Rockwell Medical has higher earnings, but lower revenue than Accuray. Accuray is trading at a lower price-to-earnings ratio than Rockwell Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rockwell Medical	$101.49M	0.57	-$480K	-$0.06	-28.00
Accuray	$458.51M	0.37	-$1.59M	-$0.02	-75.50

Is RMTI or ARAY more profitable?

Accuray has a net margin of -0.35% compared to Rockwell Medical's net margin of -2.38%. Accuray's return on equity of -4.92% beat Rockwell Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Rockwell Medical	-2.38%	-6.79%	-3.77%
Accuray	-0.35%	-4.92%	-0.58%

Do analysts rate RMTI or ARAY?

Rockwell Medical presently has a consensus target price of $4.00, indicating a potential upside of 138.10%. Accuray has a consensus target price of $5.00, indicating a potential upside of 231.13%. Given Accuray's higher possible upside, analysts clearly believe Accuray is more favorable than Rockwell Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rockwell Medical	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	3.33
Accuray	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Which has more volatility & risk, RMTI or ARAY?

Rockwell Medical has a beta of 1.83, indicating that its stock price is 83% more volatile than the S&P 500. Comparatively, Accuray has a beta of 1.26, indicating that its stock price is 26% more volatile than the S&P 500.

Does the media refer more to RMTI or ARAY?

In the previous week, Accuray had 5 more articles in the media than Rockwell Medical. MarketBeat recorded 7 mentions for Accuray and 2 mentions for Rockwell Medical. Accuray's average media sentiment score of 0.62 beat Rockwell Medical's score of 0.38 indicating that Accuray is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Rockwell Medical	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Accuray	2 Very Positive mention(s)	3 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive

Do insiders and institutionals have more ownership in RMTI or ARAY?

23.3% of Rockwell Medical shares are held by institutional investors. Comparatively, 64.1% of Accuray shares are held by institutional investors. 3.6% of Rockwell Medical shares are held by insiders. Comparatively, 4.2% of Accuray shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Accuray beats Rockwell Medical on 10 of the 17 factors compared between the two stocks.